A secondary objective of this study is to investigate how the trigeminovascular dermal blood flow response to migraine drugs oxytocin is related to serum biomarkers, such as CGRP, serum oxytocin, and sex steroids in the study participants, further elucidating the complex interactions of several hormones in migraine. This evidence concerns the gene OXT and migraine disorder.